BBJX(BJ:430489)2024-02-25 16:00Financial Performance - The company's net profit attributable to shareholders is expected to be approximately 20.83 million yuan, a decrease of 65.46% compared to 60.30 million yuan in the same period last year[3]. - Excluding the goodwill impairment, the net profit is expected to be around 30.82 million yuan, a decrease of 48% year-on-year, with the non-recurring net profit expected to drop by 44%[5]. - The parent company's operating revenue increased by 5.5% year-on-year, maintaining a gross margin of 30%[5]. Factors Affecting Profit - A significant reduction of approximately 14 million yuan in government subsidies received compared to 2022 is a major factor for the profit decline[4]. - The company anticipates a goodwill impairment provision of about 10 million yuan due to the assessment of the acquired assets from Shafeng New Material[5]. Operational Improvements - The company implemented over 20 refined management measures during the reporting period to enhance efficiency and maintain competitive advantages[5]. - The market environment has gradually improved since December 2023, contributing to better operational performance[6]. Future Outlook - Sales volume and revenue reached historical highs in January 2024, with a monthly net profit exceeding 5 million yuan[6]. - The company expects positive performance in 2024 due to the production and sales of new projects, including the first phase of the adipate ester project and biodegradable materials functional additives[6]. - The preliminary financial data is subject to audit and does not constitute a commitment to investors regarding performance[7].